1. Introduction {#s0005}
===============

National data indicate that cardiovascular disease (CVD) is one of the leading causes of death among US Hispanics/Latinos driven in part by prevalent high blood cholesterol, high blood pressure, and overweight/obesity ([@bb0180]). This may be partially due to differential dietary patterns among Mexican Americans and other Hispanic/Latino heritages compared to non-Hispanic whites and African Americans ([@bb0180]; [@bb0015]; [@bb0045]). Data from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) demonstrate that behavioral CVD risk factors (including various dietary factors ([@bb0235])) in diverse Hispanic/Latino groups can vary substantially from those in Hispanics/Latinos of Mexican heritage. This may be problematic for interpreting clinical research, as studies of Hispanics/Latinos frequently consider those of Mexican heritage representative of all US Hispanics/Latinos ([@bb0065]). The heterogeneity of dietary factors and CVD risk across Hispanic/Latino groups suggests a need for heritage-specific examinations of different dietary measures and their associations with cardiovascular risks. This will facilitate the ultimate goal of preventing cardiovascular morbidity and mortality in the US Hispanic/Latino population and its genetically, culturally, and behaviorally diverse heritage subgroups.

Some studies examined associations between diet and cardiovascular risk in specific Hispanic/Latino heritage groups (e.g., Puerto Ricans ([@bb0010]; [@bb0150]) and Cuban Americans ([@bb0115]) among others). A study using data from HCHS/SOL showed that individuals of Mexican and Dominican heritages had the lowest prevalence of favorable CVD risk profiles compared to those of Cuban, Puerto Rican, and Central and South American heritages ([@bb0130]). Another study from HCHS/SOL also found associations between DASH diet and insulin resistance ([@bb0060]). Mattei et al. examined associations between overall dietary quality (as measured using the Alternative Healthy Eating Index \[AHEI\]) and cardiometabolic risk factors and metabolic syndrome (MetS), and found different associations in the different Hispanic/Latino heritage groups represented in HCHS/SOL ([@bb0155]). Studies of additional, overall nutrition indices in this population could help identify dietary components effective in reducing MetS and therefore CVD risk specific to individual Hispanic/Latino heritage groups, facilitating the development and uptake of tailored dietary interventions among these populations.

One such index is the Dietary Approaches to Stop Hypertension (DASH) diet, originally developed to control or prevent hypertension ([@bb0145]; [@bb0050]). Numerous prior studies found associations between DASH diet and metabolic syndrome or one or more of its components ([@bb0005]; [@bb0020]; [@bb0035]; [@bb0185]; [@bb0205]; [@bb0210]; [@bb0215]; [@bb0220]). However, few studies examined DASH diet among diverse Hispanics/Latinos in connection with metabolic syndrome or its components (beyond blood pressure) ([@bb0055]; [@bb0100]; [@bb0190]; [@bb0245]). Furthermore, prior studies identified distinct associations between DASH and cardiometabolic outcomes distinct from other diet scores (e.g., metabolically obese/normal weight ([@bb0200]) and death from heart failure ([@bb0140])). These differences may reflect dietary elements emphasized by DASH score that are also particularly relevant for cardiometabolic health. Thus, a study of DASH and cardiometabolic outcomes and risk factors in diverse Hispanic/Latino groups may provide insights into heritage-specific drivers of MetS and cardiometabolic risk in the diverse Hispanic/Latino population. Our objective was to identify differences in associations between DASH diet and cardiometabolic outcomes between specific Hispanic/Latino groups, including which groups had the strongest DASH-MetS associations, as a first step towards identifying culture-specific dietary components that can reduce cardiometabolic disease risk and mortality in these populations.

2. Methods {#s0010}
==========

2.1. Study population {#s0015}
---------------------

HCHS/SOL is a prospective, community-based cohort of 16,415 participants who self-identified as Hispanic/Latino, were aged 18--74 at recruitment, and lived in randomly selected households in the areas of four US field centers (Chicago, IL; Miami, FL; Bronx, NY; and San Diego, CA). The current study used data from the HCHS/SOL baseline examinations, which were conducted from 2008 to 2011. Participants were recruited using a stratified, two-stage area probability sample of addresses in each field center. Complete details of this method were previously reported ([@bb0240]). Eligibility criteria were residence at that address, able to attend a clinic visit for data collection, and no plans to move within six months. All participants provided written informed consent. Institutional review boards for each field center and reading center, the coordinating center, and the National Heart, Lung, and Blood Institute all approved this study. The study was registered at [clinicaltrials.gov](http://clinicaltrials.gov){#ir0005} as [NCT02060344](NCT02060344){#ir0010}. In total, the HCHS/SOL sample size is 16,415 individuals. For this analysis we excluded individuals with missing data on DASH score or MetS (n = 258); triglycerides, HDL, blood pressure, and waist circumstance (n = 193); lipid-lowering medication use (n = 329); missing depression symptom (n = 247); and other missing covariates (n = 279). We further excluded individuals with diabetes (n = 3082), self-reported CVD (n = 954), or self-reported cancer (n = 332). These exclusions resulted in a final sample size of 10,741 individuals for analyses.

2.2. Data collection {#s0020}
--------------------

Full details of the HCHS/SOL data collection methodology, including field center and laboratory procedures, were described previously ([@bb0240]). Briefly, participants visited a clinic at their field center, at which all clinical assessments and interviews were conducted by personnel (trained using a central protocol) in the participant\'s preferred language. Data collection included questions on demographic (including Hispanic/Latino heritage) and socioeconomic (including highest achieved education and annual household income) characteristics, lifestyle and health behaviors (including whether they currently, ever, or never smoked), acculturation, medical history, and medication use. Acculturation measures included whether participants were born in the US, number of years living in the US if born elsewhere (0--10 vs. \>10 years for analysis), language preference (English vs. Spanish), and generational level (first vs. second or higher generation immigrant). Participants self-identified as one of eight Hispanic/Latino heritage groups: Mexican or Mexican descent, Cuban or Cuban descent, Puerto Rican or Puerto Rican descent, Dominican or Dominican descent, Central American or Central American descent, South American or South American descent, more than one heritage, or other. Due to small sample sizes, multiple and other heritage groups were combined for this analysis. Physical activity was assessed via the Global Physical Activity Questionnaire (GPAQ) ([@bb0030]; [@bb0110]), and self-reported hours of activity and sedentary behavior were converted into their metabolic equivalents and categorized as low, moderate, or high. Height was measured to the nearest centimeter and weight to the nearest 0.1 kg; from these body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Standard cut-points for BMI categories were applied (underweight \<18.5, normal 18.5--\<25, overweight 25--\<30, and obese ≥30), and due to sample size constraints underweight and normal categories were combined. Waist circumference was measured at the horizontal line immediately above the uppermost lateral border of the right ilium using non-stretchable measuring tape. Blood pressure was measured by trained, certified research staff in triplicate using an automated OMRON HEM-907 XL sphygmomanometer after a 5-minute rest, and averaged to yield the final measurement. Fasting blood samples were collected via venipuncture upon participant arrival and shipped to the central laboratory for analysis. A Roche Modular P Chemistry Analyzer was used to measure serum triglycerides, serum HDL cholesterol, and plasma glucose (Roche Diagnostics). Depressive symptoms were measured using the 10-item Center for Epidemiological Studies Depression Scale (CESD-10) as described previously ([@bb0260]). Anxiety symptoms were measured using the shortened Spielberger Trait Anxiety Scale (STAS), also as described previously ([@bb0260]).

2.3. Dietary assessment and DASH score calculation {#s0025}
--------------------------------------------------

Detailed procedures for dietary data collection have been described previously ([@bb0235]; [@bb0155]; [@bb0175]). Briefly, study coordinators administered two 24-hour dietary recalls; one in person at the baseline visit and one either over the phone or in person between five and 30 days later (\>99% of the HCHS/SOL cohort had their second dietary recall within this window). Over 88% of the recalls were unannounced, and scheduled by staff with the goal of evenly distributing them throughout the days of the week. Recalls with energy intakes below the sex-specific first or \>99th percentiles, or that were deemed unreliable by the interviewer, were excluded. Intakes were analyzed using the Nutrition Data System for Research v. 11 (Nutrition Coordinating Center, University of Minnesota), which includes Hispanic/Latino foods. DASH score was calculated using the average intakes of both dietary recalls where available (94% of the HCHS/SOL cohort had data from both dietary recalls), based on the guidelines described in [@bb0125] and the components and standards for minimum and maximum scores from Günther et al. ([@bb0060]; [@bb0095]) to be consistent with a prior study of DASH in HCHS/SOL ([@bb0060]). The eight DASH components were scored according to intakes of total and whole grains, vegetables (excluding potatoes), fruits (including juice), dairy, red/processed meat, nuts/seeds/legumes, fats/oils, and sweets on a range of 0--10. The individual components were scored according to predefined cut-points (see [Table 1](#t0005){ref-type="table"}), and added to yield an overall DASH score range of 0--80. Higher DASH scores indicate an overall healthier diet and higher component scores indicate higher consumption of grains, vegetables, fruit, dairy, and nuts/seeds/legumes and lower consumption of red/processed meat, fats/oils, and sweets.Table 1Score calculation for each DASH component.Table 1DASH component (servings/day)Serving size or unitCriteria for minimum score (0)Criteria for maximum score (10)1a. Total grains½ cup or 1 slice or 1 oz. of ready-to-eat cereal0 servings/day≥6 servings/day1b. Whole grains½ cup or 1 slice or 1 oz. of ready-to-eat cereal0% daily servings≥50% daily servings2. Vegetables1 cup of raw leafy vegetables or ½ cup cooked or raw or 4 fluid oz. of juice0 servings/day≥4 servings/day3. Fruit½ cup or one medium piece or 4 fluid oz. of juice0 servings/day≥4 servings/day4a. Total dairy1 cup milk/yogurt or 1.5 oz. natural cheese or 2 oz. processed cheese0 servings/day≥2 servings/day4b. Low-fat dairy1 cup milk/yogurt or 1.5 oz. natural cheese or 2 oz. processed cheese0% daily servings≥75% daily servings5. Meat, poultry, fish, and eggsAll meats: 1 oz.\
Eggs: 1 egg≥4 servings/day≤2 servings/day6. Nuts/seeds/legumes½ oz. nuts or 1 TB nut butters0 servings/week≥4 servings/week7. Fats/oils1 TS butter/margarine/oil/shortening or 30 g salad dressing/ sour cream or 15 g mayonnaise or 1 TB cream≥6 servings/day≤3 servings/day8. Sweets4 g sugar or 8 fluid oz≥10 servings/week≤5 servings/week[^1]

2.4. MetS definition {#s0030}
--------------------

This study used the same definition of MetS as prior HCHS/SOL studies ([@bb0105]). Briefly, we defined metabolic syndrome as the presence of three or more of the following criteria: Abdominal obesity \>102 cm in men, \>88 cm in women; elevated blood pressure (≥130/85 mmHg) or use of antihypertension medications; high triglycerides \[≥1.28 mmol/L (150 mg/dL)\]; low HDL cholesterol \[\<1.03 mmol/L (40 mg/dL) in men, \<1.28 mmol/L (50 mg/dL) in women\]; and impaired fasting glucose \[≥5.8 mmol/L (100 mg/dL)\] or use of antidiabetic medications.

2.5. Statistical analyses {#s0035}
-------------------------

We weighted reported estimates to adjust for sampling probability and nonresponse. The means of DASH score and its components were computed by Hispanic/Latino heritage and other characteristics. We divided continuous covariates into tertiles for presentation only and performed descriptive analyses of subject characteristics across heritage groups and DASH score across subject characteristics. We reported the proportions and 95% CIs for categorical variables and means and 95% CIs for continuous variables, comparing characteristics across Hispanic/Latino heritage groups using F-tests and χ^2^-tests respectively ([Table 2](#t0010){ref-type="table"}). Two groups were excluded from calculation due to small sample size- Dominicans and five Cuban participants at the San Diego site (n = 1 and 5, respectively). Next we compared mean DASH score across participant characteristics in [Table 3](#t0015){ref-type="table"}, all performed using F-tests. The associations between overall DASH score with dichotomous metabolic syndrome and each component by Hispanic/Latino heritage were examined using multivariable logistic regression and odds ratios (ORs) with 95% confidence intervals (CIs). We used linear regression analyses to examine associations of overall DASH score and each continuous MetS component by Hispanic/Latino heritage. Consistent with prior research ([@bb0155]), we rescaled DASH score to 10-unit increments for all multivariable models and log-transformed triglycerides and HDL cholesterol to ensure an approximately normal distribution (and back-transformed the corresponding model coefficients for presentation). All linear and logistic regression models adjusted for age, sex, study site, nativity, smoking status, total alcoholic drinks per week, education, household income, marital status, depressive and anxiety symptoms, baseline visit season, physical activity, energy intake, and health insurance status. All models for the overall study population (i.e., non-stratified) were additionally adjusted for Hispanic/Latino heritage. Linear regression models were additionally adjusted for medication use in the appropriate analyses (e.g., lipid-lowering medication for the triglycerides and HDL analyses only). For all of the above multivariable models we ran additional sensitivity analyses comparing the effects of dropping nativity from the covariates of interest.Table 2Subject sociodemographic, behavior, or health characteristics by Hispanic/Latino heritage group.Table 2% (95% CI)OverallMexicanCubanPuerto RicanDominicanCentral AmericanSouth AmericanMixed/otherpOverall (N)10,7414412159114609201220788350Age group\<0.001 18--44 years68.7 (67.3--70.1)74.0 (71.8--76.2)56.2 (53.4--58.9)64.2 (60.6--67.9)70.3 (66.0--74.6)73.9 (70.6--77.2)62.9 (58.6--67.3)85.3 (81.5--89.0) 45--64 years26.7 (25.5--28.0)22.9 (20.8--25.0)35.0 (32.4--37.5)29.8 (26.4--33.3)27.2 (23.3--31.1)23.4 (20.3--26.5)31.5 (27.7--35.3)12.9 (9.4--16.4) ≥65 years4.6 (4.0--5.2)3.1 (2.3--3.9)8.9 (6.8--10.9)5.9 (3.5--8.3)2.4 (1.2--3.7)2.7 (1.4--3.9)5.5 (3.2--7.8)1.8 (0.3--3.3)Sex\<0.001 Male48.6 (47.2--49.9)45.9 (43.7--48.2)54.7 (52.0--57.4)54.1 (50.6--57.7)38.4 (33.5--43.4)48.8 (44.8--52.9)47.6 (43.3--51.9)49.4 (41.4--57.5) Female51.4 (50.1--52.8)54.1 (51.8--56.3)45.3 (42.6--48.0)45.9 (42.3--49.4)61.6 (56.6--66.5)51.2 (47.1--55.2)52.4 (48.1--56.7)50.6 (42.5--58.6)BMI\<0.001 Normal/underweight25.4 (24.2--26.7)23.1 (21.2--25.0)30.6 (28.1--33.2)24.1 (20.8--27.4)22.1 (18.5--25.7)25.6 (22.1--29.1)31.2 (26.2--36.1)26.5 (19.9--33.0) Overweight38.1 (36.7--39.5)41.1 (38.6--43.6)35.7 (32.8--38.7)32.7 (29.1--36.2)37.5 (32.9--42.1)39.4 (35.7--43.2)40.8 (36.3--45.4)33.8 (27.2--40.4) Obesity36.5 (35.0--38.0)35.8 (32.9--38.7)33.6 (30.8--36.5)43.2 (39.5--46.9)40.4 (35.3--45.5)35.0 (31.9--38.1)28.0 (23.8--32.2)39.7 (33.1--46.3)Study center\<0.001 Bronx26.1 (23.2--28.9)8.0 (5.6--10.4)1.8 (0.9--2.8)69.0 (64.4--73.6)94.4 (91.8--97.0)18.1 (12.9--23.2)20.5 (15.0--26.0)42.4 (33.6--51.1) Miami30.0 (25.7--34.3)1.4 (0.8--2.1)97.0 (95.7--98.4)4.5 (2.8--6.2)4.2 (1.8--6.7)63.7 (56.3--71.2)53.4 (45.5--61.2)27.7 (19.5--35.8) Chicago16.5 (14.4--18.7)25.9 (22.0--29.7)1.3 (0.5--2.2)23.8 (19.6--28.0)0.9 (0.3--1.5)14.4 (10.5--18.3)21.9 (16.0--27.8)10.0 (6.1--14.0) San Diego27.4 (23.7--31.1)64.7 (60.1--69.3)NR[a](#tf0005){ref-type="table-fn"}2.7 (0.8--4.5)NR[a](#tf0005){ref-type="table-fn"}3.8 (2.0--5.6)4.2 (1.3--7.1)20.0 (12.6--27.3)Education\<0.001 \<High school29.0 (27.5--30.6)33.9 (31.2--36.7)16.1 (13.8--18.3)31.5 (27.7--35.3)34.1 (30.1--38.2)36.8 (33.2--40.3)20.0 (16.1--23.9)22.4 (15.2--29.5) High school30.2 (28.9--31.6)31.4 (29.2--33.6)35.3 (32.0--38.7)30.1 (27.0--33.2)23.7 (19.2--28.2)27.0 (23.8--30.3)28.4 (24.2--32.6)19.4 (12.5--26.2) \>High school40.7 (38.9--42.6)34.7 (31.2--38.2)48.6 (44.9--52.3)38.4 (34.2--42.6)42.2 (37.9--46.5)36.2 (32.5--39.8)51.6 (46.8--56.4)58.3 (50.2--66.4)Household income\<0.001 \<\$20,00039.9 (38.0--41.9)36.1 (32.6--39.5)42.6 (39.6--45.7)42.4 (38.3--46.4)46.5 (41.1--51.9)48.4 (43.8--53.0)36.1 (31.5--40.6)30.8 (24.1--37.5) \$20,000--\$50,00038.4 (36.9--39.9)43.4 (41.0--45.8)32.6 (29.4--35.8)33.3 (29.2--37.4)35.7 (30.8--40.6)34.1 (30.0--38.2)43.6 (39.0--48.1)42.8 (34.7--50.9) \>\$50,00012.6 (10.8--14.4)15.7 (12.5--18.8)8.1 (6.0--10.2)15.0 (12.1--17.9)8.6 (5.5--11.7)6.7 (4.5--8.9)11.4 (8.4--14.4)18.4 (12.1--24.8) Not reported9.1 (8.1--10.0)4.9 (4.0--5.8)16.7 (14.2--19.2)9.4 (7.4--11.4)9.3 (6.8--11.7)10.8 (8.6--13.0)8.9 (6.1--11.7)7.9 (4.0--11.9)Energy intake\<0.001 Tertile 130.1 (28.6--31.6)29.4 (27.3--31.6)14.8 (12.8--16.7)35.0 (31.6--38.4)56.5 (51.4--61.6)33.4 (29.5--37.2)26.0 (22.0--29.9)32.7 (25.5--39.9) Tertile 234.0 (32.7--35.3)36.4 (34.2--38.5)32.2 (29.2--35.2)29.9 (27.0--32.9)29.1 (24.6--33.7)35.7 (32.6--38.9)37.6 (33.2--42.0)36.2 (29.1--43.2) Tertile 335.9 (34.3--37.6)34.2 (31.9--36.5)53.1 (49.9--56.2)35.1 (31.9--38.2)14.4 (11.2--17.5)30.9 (26.9--34.9)36.4 (32.2--40.6)31.1 (23.7--38.6)Marital status\<0.001 Single36.9 (35.5--38.3)28.0 (25.9--30.1)36.3 (33.2--39.3)54.5 (51.0--57.9)45.7 (41.5--49.9)39.4 (35.9--42.8)37.3 (33.2--41.3)41.8 (34.6--49.0) Married/cohabiting49.5 (47.8--51.3)59.9 (57.3--62.6)49.0 (45.7--52.4)31.5 (28.0--35.1)39.0 (34.6--43.4)48.1 (44.6--51.7)47.8 (43.3--52.3)39.5 (32.2--46.7) No longer married13.6 (12.7--14.6)12.1 (10.5--13.6)14.7 (12.7--16.7)14.0 (11.6--16.4)15.3 (12.8--17.8)12.5 (10.6--14.4)14.9 (11.7--18.1)18.7 (14.1--23.4)US residence\<0.001 US-born24.5 (22.8--26.1)24.1 (21.7--26.5)12.2 (9.6--14.8)56.5 (52.8--60.3)16.7 (12.6--20.8)6.5 (3.9--9.1)8.5 (5.9--11.1)54.0 (46.7--61.3) 0--10 years31.0 (29.0--33.1)25.3 (22.8--27.7)56.4 (52.6--60.2)8.0 (5.7--10.2)26.2 (21.8--30.6)41.3 (36.7--45.9)45.2 (40.2--50.2)12.2 (6.4--18.1) \>10 years44.5 (42.9--46.1)50.7 (47.9--53.4)31.4 (28.2--34.5)35.5 (32.4--38.5)57.1 (52.9--61.3)52.3 (48.3--56.2)46.3 (41.7--50.9)33.7 (26.5--41.0)Language preference\<0.001 English25.9 (23.9--27.8)22.0 (19.6--24.4)11.4 (9.3--13.5)64.5 (60.2--68.7)25.1 (19.5--30.6)11.0 (7.6--14.4)13.4 (10.4--16.5)52.3 (44.2--60.4) Spanish74.1 (72.2--76.1)78.0 (75.6--80.4)88.6 (86.5--90.7)35.5 (31.3--39.8)74.9 (69.4--80.5)89.0 (85.6--92.4)86.6 (83.5--89.6)47.7 (39.6--55.8)Smoking status\<0.001 Never63.6 (62.1--65.0)64.9 (62.4--67.4)59.1 (55.9--62.2)53.3 (49.4--57.3)79.0 (74.7--83.2)70.3 (66.8--73.9)66.2 (61.2--71.3)54.7 (46.9--62.4) Former15.0 (14.1--16.0)17.5 (15.9--19.2)13.1 (11.3--15.0)12.2 (9.9--14.5)9.0 (7.1--10.9)13.7 (11.4--16.1)20.4 (16.9--23.9)18.5 (13.2--23.8) Current21.4 (20.1--22.7)17.6 (15.6--19.6)27.8 (25.1--30.6)34.5 (31.0--38.0)12.0 (7.9--16.1)16.0 (13.2--18.8)13.4 (9.8--17.0)26.8 (19.6--34.1)Physical Activity (GPAQ)\<0.001 Tertile 130.7 (29.3--32.1)27.8 (25.9--29.7)39.8 (36.7--42.8)28.0 (24.5--31.5)32.2 (28.1--36.2)30.8 (27.2--34.5)26.8 (23.2--30.5)24.3 (19.1--29.5) Tertile 234.6 (33.3--35.9)35.8 (33.6--38.0)31.8 (29.2--34.4)33.6 (30.5--36.7)35.3 (31.3--39.4)29.2 (26.3--32.2)40.1 (35.7--44.5)42.1 (33.9--50.2) Tertile 334.7 (33.3--36.1)36.4 (34.0--38.7)28.4 (25.5--31.4)38.4 (34.7--42.1)32.5 (27.6--37.4)39.9 (36.0--43.8)33.1 (28.1--38.1)33.7 (26.3--41.0)Anxiety Symptoms Score (STAS)\<0.001 Tertile 142.0 (40.5--43.6)39.9 (37.2--42.7)50.0 (47.2--52.9)35.2 (31.6--38.8)39.6 (35.0--44.2)45.2 (41.1--49.2)46.8 (42.3--51.4)39.5 (32.2--46.7) Tertile 231.3 (29.9--32.7)32.8 (30.5--35.1)28.9 (26.2--31.7)29.7 (26.1--33.2)32.9 (28.5--37.3)29.4 (25.8--33.0)33.1 (28.2--38.1)31.6 (24.4--38.8) Tertile 326.7 (25.4--28.0)27.3 (25.0--29.5)21.0 (18.8--23.3)35.2 (31.9--38.4)27.5 (23.2--31.7)25.4 (22.2--28.6)20.1 (16.3--23.8)29.0 (22.5--35.4)Depressive Symptoms Score (CESD-10)\<0.001 0--976.0 (74.7--77.3)78.9 (76.8--81.1)76.4 (74.1--78.7)67.0 (63.8--70.3)75.2 (71.0--79.4)77.1 (74.1--80.1)77.8 (74.0--81.5)73.4 (67.0--79.8) 10+24.0 (22.7--25.3)21.1 (18.9--23.2)23.6 (21.3--25.9)33.0 (29.7--36.2)24.8 (20.6--29.0)22.9 (19.9--25.9)22.2 (18.5--26.0)26.6 (20.2--33.0)Season of Baseline Data Collection0.526 Fall23.4 (21.0--25.8)23.6 (20.0--27.1)26.6 (21.4--31.9)19.3 (15.4--23.2)22.7 (16.5--29.0)23.7 (18.8--28.7)20.2 (15.0--25.5)24.0 (16.1--31.9) Winter22.1 (20.1--24.2)22.7 (19.4--26.1)19.9 (16.1--23.7)21.4 (17.8--25.0)21.5 (16.8--26.2)25.2 (20.9--29.5)23.8 (18.2--29.3)22.9 (17.3--28.5) Spring27.7 (25.4--29.9)25.5 (22.4--28.6)28.4 (23.0--33.8)30.5 (26.4--34.7)30.7 (24.8--36.6)27.3 (21.6--32.9)30.0 (24.5--35.5)26.9 (20.0--33.7) Summer26.8 (24.5--29.1)28.2 (24.4--32.0)25.1 (20.7--29.4)28.7 (23.8--33.7)25.0 (20.7--29.4)23.8 (18.7--28.9)26.0 (19.5--32.5)26.2 (19.6--32.8)Alcohol consumption\<0.001 None45.2 (43.4--47.0)44.1 (41.0--47.2)48.6 (45.0--52.2)45.5 (42.0--49.0)40.0 (35.2--44.8)53.1 (49.5--56.8)46.9 (42.1--51.7)33.9 (26.9--40.9) 0--2 drinks/week48.4 (46.6--50.1)49.7 (46.7--52.7)45.0 (41.5--48.5)47.1 (43.3--50.8)53.3 (49.0--57.5)41.3 (37.6--45.1)49.0 (44.4--53.6)57.5 (49.9--65.0) \>2 drinks/week6.4 (5.7--7.1)6.2 (5.1--7.3)6.4 (4.9--7.9)7.4 (5.3--9.5)6.7 (4.3--9.1)5.5 (3.9--7.1)4.1 (2.4--5.8)8.6 (4.5--12.7)Health insurance\<0.001 Any46.0 (44.0--48.1)40.4 (37.3--43.5)34.1 (30.6--37.5)75.7 (72.5--78.9)68.1 (63.1--73.1)28.1 (23.8--32.3)38.0 (32.9--43.0)55.8 (47.6--64.1) None54.0 (51.9--56.0)59.6 (56.5--62.7)65.9 (62.5--69.4)24.3 (21.1--27.5)31.9 (26.9--36.9)71.9 (67.7--76.2)62.0 (57.0--67.1)44.2 (35.9--52.4)Metabolic syndrome\<0.001 No76.1 (74.9--77.3)75.8 (73.7--77.9)75.9 (73.4--78.4)73.5 (70.1--76.8)81.4 (78.3--84.6)75.4 (72.4--78.3)81.5 (78.1--84.9)70.5 (63.5--77.5) Yes23.9 (22.7--25.1)24.2 (22.1--26.3)24.1 (21.6--26.6)26.5 (23.2--29.9)18.6 (15.4--21.7)24.6 (21.7--27.6)18.5 (15.1--21.9)29.5 (22.5--36.5)Systolic BP (mm Hg), mean (95% CI)117.8 (117.4--118.2)116.1 (115.4--116.7)119.2 (118.4--119.9)119.3 (118.4--120.2)119.2 (117.7--120.6)119.7 (118.6--120.9)115.7 (114.5--116.9)118.7 (117.0--120.4)\<0.001Diastolic BP (mm Hg), mean (95% CI)71.5 (71.2--71.9)69.6 (69.0--70.1)73.6 (73.0--74.3)72.6 (71.9--73.2)73.7 (72.8--74.6)73.0 (72.2--73.8)69.2 (68.3--70.2)72.2 (70.8--73.5)\<0.001High blood pressure\<0.001 No75.6 (74.5--76.7)79.5 (77.7--81.2)70.8 (68.6--72.9)71.7 (68.7--74.6)73.4 (70.3--76.5)74.3 (71.6--76.9)82.8 (79.9--85.6)73.0 (68.4--77.5) Yes24.4 (23.3--25.5)20.5 (18.8--22.3)29.2 (27.1--31.4)28.3 (25.4--31.3)26.6 (23.5--29.7)25.7 (23.1--28.4)17.2 (14.4--20.1)27.0 (22.5--31.6)Triglycerides (mg/dL), mean (95% CI)125.7 (123.3--128.1)128.8 (125.1--132.5)128.1 (121.4--134.7)122.2 (114.4--130.1)101.8 (96.4--107.2)140.8 (133.8--147.9)124.4 (118.0--130.9)123.6 (113.7--133.5)\<0.001High triglycerides\<0.001 No74.2 (73.0--75.3)72.5 (70.6--74.3)74.8 (72.0--77.6)75.8 (72.5--79.2)85.3 (82.7--87.8)66.8 (63.6--70.1)72.2 (68.2--76.3)73.8 (66.3--81.3) Yes25.8 (24.7--27.0)27.5 (25.7--29.4)25.2 (22.4--28.0)24.2 (20.8--27.5)14.7 (12.2--17.3)33.2 (29.9--36.4)27.8 (23.7--31.8)26.2 (18.7--33.7)HDL (mg/dL), mean (95% CI)48.8 (48.4--49.1)49.0 (48.4--49.5)47.8 (47.0--48.5)47.4 (46.5--48.3)50.8 (49.7--52.0)48.5 (47.5--49.4)49.5 (48.4--50.7)50.6 (48.5--52.6)\<0.001Low HDL0.309 No59.9 (58.4--61.3)60.0 (57.5--62.6)59.5 (56.6--62.4)56.7 (53.2--60.3)62.3 (56.7--67.9)57.5 (54.1--60.8)64.2 (59.5--68.9)63.1 (55.9--70.4) Yes40.1 (38.7--41.6)40.0 (37.4--42.5)40.5 (37.6--43.4)43.3 (39.7--46.8)37.7 (32.1--43.3)42.5 (39.2--45.9)35.8 (31.1--40.5)36.9 (29.6--44.1)Glucose (mg/dL), mean (95% CI)93.3 (93.1--93.6)93.5 (93.1--93.8)93.8 (93.3--94.3)93.2 (92.5--93.9)91.8 (91.0--92.5)93.7 (93.2--94.2)93.5 (92.7--94.3)93.3 (92.2--94.4)\<0.001Impaired fasting glucose0.008 No79.3 (78.2--80.4)78.6 (76.8--80.4)78.8 (76.3--81.2)79.1 (76.0--82.2)82.7 (79.4--85.9)80.7 (78.2--83.1)80.7 (77.1--84.3)77.9 (72.8--82.9) Yes20.7 (19.6--21.8)21.4 (19.6--23.2)21.2 (18.8--23.7)20.9 (17.8--24.0)17.3 (14.1--20.6)19.3 (16.9--21.8)19.3 (15.7--22.9)22.1 (17.1--27.2)Waist circumference (cm), mean (95% CI)95.8 (95.3--96.3)96.7 (96.0--97.5)94.6 (93.7--95.5)97.1 (96.1--98.1)95.0 (93.2--96.9)94.1 (93.2--95.0)92.5 (91.2--93.8)97.5 (95.0--100.0)\<0.001High waist circumference\<0.001 No49.3 (47.7--51.0)45.5 (42.8--48.3)55.2 (52.4--57.9)46.9 (43.5--50.3)47.9 (43.1--52.8)52.3 (48.9--55.7)61.5 (56.5--66.5)47.6 (40.0--55.1) Yes50.7 (49.0--52.3)54.5 (51.7--57.2)44.8 (42.1--47.6)53.1 (49.7--56.5)52.1 (47.2--56.9)47.7 (44.3--51.1)38.5 (33.5--43.5)52.4 (44.9--60.0)[^2][^3]Table 3Average DASH score by sociodemographic, behavior, or health characteristics (n = 10,741).Table 3CharacteristicDASH score (0--80) mean + 95% CIpCharacteristicDASH score (0--80) mean + 95% CIpOverall34.3 (33.9--34.6)Marital status\<0.001Age group\<0.001 Single32.6 (32.1--33.2) 18--44 years33.8 (33.3--34.3) Married/cohabiting35.3 (34.8--35.7) 45--64 years35.0 (34.5--35.5) No longer married35.2 (34.6--35.9) ≥65 years37.4 (36.0--38.7)US residence\<0.001Sex\<0.001 US-born32.2 (31.6--32.8) Male33.1 (32.6--33.6) 0--10 years34.0 (33.4--34.6) Female35.4 (34.9--35.8) \>10 years35.6 (35.2--36.1)BMI, kg/m^2^0.201Language preference\<0.001 Normal/underweight34.4 (33.7--35.1) English35.0 (34.5--35.4) Overweight34.5 (34.0--35.0) Spanish32.3 (31.7--33.0) Obesity33.9 (33.4--34.4)Smoking status\<0.001Heritage group\<0.001 Never35.3 (34.9--35.7) Mexican37.4 (36.9--37.9) Former34.7 (33.9--35.4) Cuban31.5 (31.0--32.1) Current31.0 (30.3--31.8) Puerto Rican31.1 (30.3--31.9)Physical Activity (GPAQ)0.002 Dominican33.7 (32.7--34.6) Tertile 133.8 (33.2--34.3) Central American33.0 (32.3--33.8) Tertile 234.9 (34.4--35.4) South American32.5 (31.4--33.5) Tertile 334.1 (33.5--34.7) Mixed/other34.3 (32.6--36.0)Anxiety Symptoms Score (STAS)0.206Study center\<0.001 Tertile 134.6 (34.0--35.1) Bronx32.5 (31.9--33.1) Tertile 234.2 (33.6--34.8) Miami36.7 (36.0--37.3) Tertile 333.9 (33.3--34.5) Chicago32.0 (31.5--32.5)Depressive Symptoms Score (CESD-10)0.008 San Diego37.0 (36.4--37.7) 0--934.5 (34.1--34.9)Education0.007 10+33.6 (32.9--34.2) \<High school34.2 (33.7--34.7)Season of Baseline Data Collection0.539 High school33.7 (33.0--34.3) Fall33.9 (33.2--34.7) \>High school34.8 (34.3--35.3) Winter34.2 (33.6--34.9)Household income\<0.001 Spring34.6 (34.0--35.3) \<\$20,00033.9 (33.3--34.4) Summer34.3 (33.6--34.9) \$20,000--\$50,00034.9 (34.4--35.3)Alcohol consumption\<0.001 \>\$50,00035.2 (34.2--36.3) None35.2 (34.7--35.7) Not reported32.3 (31.4--33.2) 0--2 drinks/week33.8 (33.3--34.2)Energy intake\<0.001 \>2 drinks/week31.3 (30.0--32.7) Tertile 135.4 (34.8--35.9)Health insurance0.295 Tertile 234.6 (34.0--35.1) Any34.4 (34.0--34.9) Tertile 333.1 (32.6--33.6) None34.1 (33.6--34.6)Metabolic syndrome0.950Low HDL0.372 No34.3 (33.9--34.7) No34.4 (33.9--34.9) Yes34.3 (33.7--34.9) Yes34.1 (33.6--34.6)High blood pressure0.554Impaired fasting glucose0.093 No34.3 (33.9--34.7) No34.4 (34.0--34.8) Yes34.1 (33.6--34.7) Yes33.8 (33.2--34.4)High triglycerides0.603High waist circumference0.017 No34.2 (33.8--34.7) No33.9 (33.4--34.4) Yes34.4 (33.8--35.0) Yes34.6 (34.2--35.1)[^4]

Next we assessed effect modification by including interaction terms between overall DASH score and Hispanic/Latino heritage for each outcome of interest. To facilitate comparisons with the prior study of MetS and AHEI in HCHS/SOL ([@bb0155]), we conducted sensitivity analyses to examine the association between overall DASH score and dichotomous metabolic syndrome using the same covariates and exclusion criteria as reported previously ([@bb0155]). All analyses used survey-specific procedures to account for the 2-stage sampling design, cluster sampling, and stratification. All analyses used SAS 9.4, and a p-value of \<0.05 was considered statistically significant.

3. Results {#s0040}
==========

We found a weighted prevalence of MetS in HCHS/SOL of 23.9% (95% CI: 22.7--25.2). [Table 2](#t0010){ref-type="table"} shows the characteristics of our study population overall and by Hispanic/Latino heritage group. Briefly the prevalences of MetS, high blood pressure, high triglycerides, and high waist circumference tended to vary by Hispanic/Latino heritage group as did blood pressure, triglycerides, HDL, glucose, and waist circumference when measured continuously. [Table 3](#t0015){ref-type="table"} shows mean DASH score by characteristics of our study population. Overall, mean DASH score was 34.3 (95% CI, 33.9--34.6) ranging from 4.53 to 74.75. DASH scores tended to be highest among those with Mexican heritage (mean score 37.4, 95% CI, 36.9--37.9) and lowest among those with Puerto Rican heritage (mean 31.1, 95% CI 30.3--31.9 for differences across all heritage groups). DASH also tended to be higher among those recruited from the Miami and San Diego centers, and those with a higher household income or education. Finally, DASH scores tended to be higher in those who were married, living in the US for \>10 years but not US-born, English speaking, never smokers, who were more physical active, and who had lower depression symptoms scores.

[Table 4](#t0020){ref-type="table"} shows the odds ratios for associations of MetS and its five components per 10-unit increase in DASH score overall and by Hispanic/Latino heritage group. DASH score was associated with lower odds of MetS in Central Americans (OR: 0.82, 95% CI: 0.69--0.96), increased odds of high triglycerides in those with mixed or other heritage (OR: 1.47, 95% CI: 1.04--2.09), lower odds of impaired fasting glucose both overall and in those with Mexican heritage (OR: 0.91, 95% CI: 0.85--0.98; OR: 0.87, 95% CI: 0.78--0.97), and lower odds of high waist circumference in those with mixed or other heritage (OR: 0.63, 95% CI: 0.48--0.82). Removing nativity from these models did not substantively change our results (Table S1).Table 4ORs (95% CIs) for associations between 10-unit increase in DASH score and MetS/components by Hispanic/Latino heritage group.Table 4NMetabolic syndromeHigh blood pressureHigh triglyceridesLow HDLImpaired fasting glucoseHigh waist circumferenceAll10,7410.95 (0.88, 1.02)0.95 (0.88, 1.01)0.99 (0.92, 1.07)0.96 (0.91, 1.02)0.91 (0.85, 0.98)[⁎](#tf0010){ref-type="table-fn"}0.95 (0.89, 1.01)Mexican44120.94 (0.84, 1.05)1.02 (0.91, 1.15)0.99 (0.89, 1.11)1.02 (0.92, 1.13)0.87 (0.78, 0.97)[⁎](#tf0010){ref-type="table-fn"}1.01 (0.91, 1.11)Cuban15910.99 (0.84, 1.18)0.97 (0.83, 1.13)1.06 (0.92, 1.22)0.94 (0.83, 1.07)1.01 (0.86, 1.17)1.00 (0.84, 1.17)Puerto Rican14600.95 (0.78, 1.15)0.91 (0.78, 1.06)0.94 (0.79, 1.13)0.88 (0.76, 1.02)0.96 (0.78, 1.17)0.91 (0.77, 1.08)Dominican9200.87 (0.72, 1.05)0.82 (0.65, 1.03)0.89 (0.70, 1.12)0.97 (0.81, 1.15)0.86 (0.68, 1.10)0.89 (0.76, 1.06)Central American12200.82 (0.69, 0.96)[⁎](#tf0010){ref-type="table-fn"}0.93 (0.77, 1.13)0.85 (0.71, 1.01)0.88 (0.76, 1.03)0.85 (0.69, 1.04)0.88 (0.76, 1.02)South American7880.86 (0.68, 1.07)0.81 (0.64, 1.02)1.00 (0.80, 1.25)0.83 (0.67, 1.02)0.83 (0.63, 1.10)0.84 (0.69, 1.01)Mixed/other3501.28 (0.92, 1.77)0.73 (0.51, 1.03)1.47 (1.04, 2.09)[⁎](#tf0010){ref-type="table-fn"}1.22 (0.93, 1.61)1.02 (0.68, 1.52)0.63 (0.48, 0.82)[⁎⁎](#tf0020){ref-type="table-fn"}p~interaction~[\#](#tf0025){ref-type="table-fn"}0.470.660.350.160.250.26[^5][^6][^7][^8][^9][^10]

[Table 5](#t0025){ref-type="table"} shows the regression coefficients from the linear regression of DASH score and MetS components, overall and by Hispanic/Latino heritage group. Overall DASH score was associated with systolic (B: −0.36, 95% CI: −0.69, −0.02) and diastolic blood pressure (B: −0.62, 95% CI: −0.88, −0.35) as well as fasting glucose (B: −0.39, 95% CI: −0.61, −0.17) and waist circumference (B: −0.70, 95% CI: −1.10, −0.30). DASH score was also associated with systolic blood pressure in Hispanics/Latinos of South Americans heritage (B: −0.89, 95% CI: −1.78, −0.004); diastolic blood pressure in Hispanics/Latinos of Central American (B: −0.73, 95% CI: −1.45, −0.01) and South American heritages (B: −1.17, 95% CI: −1.86, −0.48); triglycerides (B: −6.28, 95% CI: −12.29, −0.28) and HDL (B: 0.89, 95% CI: 0.03, 1.74) in those of Central American heritage; fasting glucose in those of Mexican heritage (B: −0.48, 95% CI: −0.80, −0.15); and waist circumference in those of Dominican (B: −1.61, 95% CI: −3.07, −0.15) and South American (B: −1.42, 95% CI: −2.48, −0.37) heritages. Removing nativity from these models did not substantially change our results, although our finding linking diet and HDL in Central Americans became marginally significant (Table S2). Our sensitivity analysis also found largely null results for the association between overall DASH score and MetS prevalence, though in this model DASH was protective against MetS in Central Americans (OR: 0.76, 95% CI: 0.64--0.91; remaining data available upon request).Table 5Average change in each MetS risk factor per each 10-unit overall DASH score increase and cardiometabolic outcomes by Hispanic/Latino heritage group (n = 10,741).Table 5Systolic BP (mm Hg)Diastolic BP (mm Hg)Triglycerides (mg/dL)HDL (mg/dL)Glucose (mg/dL)Waist circumference (cm)NB (95% CI)B (95% CI)B (95% CI)B (95% CI)B (95% CI)B (95% CI)All10,741-0.36 (−0.69, −0.02)[⁎](#tf0030){ref-type="table-fn"}-0.62 (−0.88, −0.35)[⁎⁎⁎](#tf0040){ref-type="table-fn"}-0.48 (−3.20, 2.24)0.11 (−0.24, 0.46)−0.39 (−0.61, −0.17)[⁎⁎⁎](#tf0040){ref-type="table-fn"}−0.70 (−1.10, −0.30)[⁎⁎⁎](#tf0040){ref-type="table-fn"}Mexican4412−0.23 (−0.78, 0.31)−0.43 (−0.88, 0.02)−0.55 (−4.74, 3.64)−0.27 (−0.88, 0.33)−0.48 (−0.80, −0.15)[⁎⁎](#tf0035){ref-type="table-fn"}−0.37 (−0.98, 0.24)Cuban1591−0.20 (−1.08, 0.68)−0.57 (−1.21, 0.08)−3.35 (−11.42, 4.73)0.22 (−0.50, 0.94)−0.25 (−0.70, 0.19)−0.40 (−1.33, 0.54)Puerto Rican1460−0.46 (−1.35, 0.43)−0.60 (−1.25, 0.06)3.08 (−3.76, 9.92)0.39 (−0.39, 1.17)−0.31 (−0.92, 0.30)−0.96 (−2.04, 0.11)Dominican920−0.30 (−1.29, 0.69)−0.50 (−1.23, 0.23)−1.88 (−6.59, 2.82)0.24 (−0.63, 1.11)−0.46 (−1.11, 0.19)−1.61 (−3.07, −0.15)[⁎](#tf0030){ref-type="table-fn"}Central American1220−0.13 (−1.18, 0.92)−0.73 (−1.45, −0.01)[⁎](#tf0030){ref-type="table-fn"}−6.28 (−12.29, −0.28)[⁎](#tf0030){ref-type="table-fn"}0.89 (0.03, 1.74)[⁎](#tf0030){ref-type="table-fn"}−0.23 (−0.72, 0.26)−0.82 (−1.78, 0.14)South American788−0.89 (−1.78, −0.004)[⁎](#tf0030){ref-type="table-fn"}−1.17 (−1.86, −0.48)[⁎⁎⁎](#tf0040){ref-type="table-fn"}−0.37 (−6.43, 5.69)0.27 (−0.77, 1.30)−0.74 (−1.53, 0.05)−1.28 (−2.24, −0.32)[⁎⁎](#tf0035){ref-type="table-fn"}Mixed/other350−0.32 (−1.48, 0.84)−1.04 (−2.17, 0.08)6.31 (−2.71, 15.33)0.50 (−1.05, 2.04)−0.21 (−1.08, 0.67)−0.74 (−2.54, 1.06)p~interaction~[\#](#tf0045){ref-type="table-fn"}0.650.420.110.450.500.30[^11][^12][^13][^14][^15][^16][^17]

4. Discussion {#s0045}
=============

In this study, we found that DASH diet scores tended to vary by Hispanic/Latino heritage group. While few dichotomous MetS components were associated with DASH, we did find associations between DASH diet score and high triglycerides, fasting glucose, and waist circumference as well as between DASH and MetS prevalence in Central Americans. Our stratified analyses suggest that these associations were driven primarily by Hispanics/Latinos of Central and South American heritages. Higher DASH score was associated with lower blood pressure in each of these groups and overall, lower fasting glucose in those with Mexican heritage, lower triglycerides and HDL in those with Central American heritage, and lower waist circumference in those with South American heritage. DASH score was associated with the largest number of MetS components of interest in those with Central and South American heritages as well. These findings add to the literature on the complex relationships between diet and cardiometabolic health among Hispanics/Latinos of diverse heritages, and contrasting these studies may add important information on the mechanisms driving cardiometabolic outcomes in these populations.

Few prior studies specifically examined the DASH diet in diverse Hispanic/Latino groups. Two prior studies of DASH in Puerto Ricans found generally low scores ([@bb0160]; [@bb0195]) and a third study of older (primarily Mexican-American) Latinos found only moderate scores ([@bb0245]) and suggested that lower scores among Hispanics/Latinos might reflect a possible need to adapt the DASH dietary scoring regimen to traditional Latino foods. A study by [@bb0255] found differences in DASH adherence by measurement method in Hispanics/Latinos, further suggesting that DASH scoring may need to be adapted to Hispanic/Latino cuisine and culture. These findings may explain why, despite prior reports of associations between DASH and diabetes/insulin resistance in Hispanics/Latinos ([@bb0055]) and DASH and MetS in Middle Eastern ([@bb0005]; [@bb0020]; [@bb0220]), Asian ([@bb0035]), Mediterranean ([@bb0205]), African-American ([@bb0210]), and Western ([@bb0185]; [@bb0215]) populations, we and others ([@bb0160]) found largely null associations among Hispanics/Latinos.

Several scoring systems have been used to measure adherence to a DASH dietary pattern. Each system assigns equal weight to each of the components of the DASH dietary pattern. Whereas some algorithms rely on food-based criteria ([@bb0095]; [@bb0070]; [@bb0090]), others use nutrient-based scoring systems ([@bb0165]), while still others use a combination of food and nutrient criteria ([@bb0085]). Some indices rely on absolute quantities ([@bb0095]; [@bb0070]; [@bb0085]), while others assign scores based on quantiles of intake ([@bb0090]; [@bb0080]). Finally some derive cut-points based on participant characteristics (i.e., sex, age, activity level) ([@bb0095]), whereas others apply the same criteria to all individuals ([@bb0165]). While DASH dietary scores are moderately correlated with one another (0.44--0.58) ([@bb0135]), a study comparing four of the DASH dietary pattern scoring approaches reported different associations with colorectal cancer among women ([@bb0170]). We chose to use a food-based scoring system to characterize the DASH diet, as this could more easily translate into public health recommendations. However additional work investigating whether nutrient-based scoring approaches yield different findings, particularly in diverse Hispanic/Latino populations, may be warranted.

Misclassification of dietary intakes in US Hispanic/Latino populations may also help explain our lack of significant results ([@bb0175]; [@bb0025]). Two of the heritage groups that we studied, Central and South Americans, had significant DASH-MetS component associations in our continuous analysis. A prior study of DASH and MetS in a Brazilian population also found associations between DASH and MetS ([@bb0075]). This suggests that DASH may be better adapted to the traditional diets of these populations than to those of Hispanics/Latinos of other heritages. Together, these findings point towards a need for further research studying the ability of DASH to capture dietary health impacts in Central- and South-American populations, and for a culturally sensitive adaptation of DASH to Hispanics/Latinos of other heritage groups. However our null findings for DASH and MetS in Central Americans belie the significant associations between DASH and three continuous MetS components; as posited previously ([@bb0155]) this discontinuity may reflect additional effect modification by age and/or sex which was not feasible to test in the present study. Future research should explore these possibilities.

A prior study of diet and MetS in HCHS/SOL ([@bb0155]) found that the AHEI 2010 dietary quality measure was associated with reduced odds of MetS. AHEI was associated with MetS (overall OR = 0.78, 95% CI 0.67--0.91) ([@bb0155]), while DASH was not in our analysis. AHEI was also associated with a greater number of continuous MetS components in those with Mexicans and Puerto Rican heritages, while in our study DASH was associated with a greater number of continuous MetS components in those with Central and South American heritages. The differences in these findings suggest that the DASH and AHEI scores may capture components of unhealthy diet that are more relevant to developing MetS in Hispanics/Latinos of different heritage groups. Our sensitivity analysis using the same covariates and selection criteria as [@bb0155] found only a single protective effect of DASH on MetS, also in Central Americans (though still a weaker effect than that found with the AHEI). This suggests that the differences between the two studies are reflective of differences in the nutritional information captured by the two scores. While components of DASH and AHEI overlap (e.g., fruit, vegetables, sodium), they use different scoring rubrics for sugar, meat, and fat intakes, and the AHEI includes alcohol while DASH does not ([@bb0225]); in HCHS/SOL, the two overall scores have a correlation of r = 0.48. A prior study from HCHS/SOL identified substantial variation in intakes of specific food groups and nutrients by Hispanic/Latino heritage group ([@bb0235]), and our descriptive analysis also found variation in DASH score by heritage, which may help explain the differences in associations between the two dietary scores in different heritage groups. For example, Hispanics/Latinos of Central American heritages were reported to have slightly lower intakes of processed meat (a specific component of DASH but not of AHEI) than those of other heritage groups. Thus, DASH may capture healthy elements of diet specific to the traditional foods of one or both of these heritage groups. Alternatively, differences in genetic admixture between these populations may explain the different findings between the two studies ([@bb0155]; [@bb0040]; [@bb0230]). A genetic component may also explain the prior findings of DASH dietary studies in different Hispanic/Latino populations. The Multiethnic Cohort found a small protective effect of DASH diet on all-cause mortality among Hispanic women only ([@bb0100]), while one longitudinal study (the Multi-Ethnic Study of Atherosclerosis) found no association between DASH diet score and either waist circumference or diabetes among Hispanics ([@bb0190]). Finally, two small studies of older Hispanics/Latinos (primarily Mexican-Americans) found that DASH diet was protective against hypertension ([@bb0055]; [@bb0245]). Future research should explore these possible explanations for the differential associations between both dietary score methods and MetS and its components.

This study has limitations. First, the cross-sectional nature of this analysis limits ability to infer temporality; individuals with higher blood pressure may change their diet in response to a recommendation or intervention by a health professional. However, it should be noted that our observed associations all suggest null or protective relationships, consistent with previously published prospective studies of DASH and various cardiometabolic endpoints in other populations ([@bb0225]; [@bb0120]). Second, as with many dietary studies in HCHS/SOL, the use of 24-hour dietary recalls may suffer from measurement error ([@bb0175]) that underestimates dietary quality ([@bb0250]). As discussed above, DASH diet may omit or misclassify traditional elements of some Hispanic/Latino diets that are relevant to MetS and its related conditions. Thus validated, culturally-sensitive dietary measures may be warranted in this population. Third, although our analytical design was driven by hypothesized differences between heritage groups and by the prior work in HCHS/SOL, the number of comparisons does leave potential inflation of our type I error a concern. Thus these findings should be interpreted with caution until they can be independently validated. Finally our observed effect sizes, even where statistically significant, were generally small and thus may be of limited clinical significance. Nonetheless, by contrasting this study with other examinations of diet quality in HCHS/SOL, we add useful information to the literature on diet-related health risks in Hispanics/Latinos in the US.

5. Conclusions {#s0050}
==============

Overall, DASH was not associated with MetS in this study from the HCHS/SOL, the largest epidemiological study of diverse Hispanics/Latinos in the US. In contrast to a prior study ([@bb0155]) demonstrating associations between MetS and the AHEI, DASH revealed stronger associations with MetS components in Hispanics/Latinos of Central and South American heritages, in contrast to the stronger associations of AHEI with MetS overall and its components in Hispanics/Latinos of Mexican and Puerto Rican heritages. This contrast suggests that DASH scoring may better capture health effects of traditional diets in some Hispanic/Latino heritage groups, adding evidence that Hispanics/Latinos of diverse heritages should not be grouped together in population-based studies but rather analyzed in a heritage group-specific manner. These findings also add evidence suggesting that AHEI or Mediterranean diet score (or possibly an adapted DASH diet score) may be more applicable to traditional Hispanic/Latino diets and health; future research should explore these possibilities. Future research should also examine differences associated with specific heritage groups, and potential explanations for them (e.g., geographic proximity to the US and its 'western' dietary pattern, specific ingredients driving the observed associations, interactions with sociocultural factors, and genetic heritage differences between groups).
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[^1]: Abbreviations: DASH = Dietary Approaches to Stop Hypertension; ox = ounce; g = gram.

[^2]: All values were weighted for survey design and nonresponse and adjusted for age.

[^3]: Not reported due to small sample size.

[^4]: Abbreviations: BMI (Body Mass Index).

[^5]: MetS was defined as three or more of the following components: High waist circumference, \>102 cm in men, \>88 cm in women; high blood pressure, \>130/85 mmHg or use of antihypertension medications; high triglycerides, \>1.28 mmol/L (150 mg/dL); low HDL, \<1.03 mmol/L (40 mg/dL) in men, \<1.28 mmol/L (50 mg/dL) in women; and impaired fasting glucose, \>5.8 mmol/L (100 mg/dL) or use of antidiabetic medications.

[^6]: The overall model adjusted for Hispanic/Latino heritage group (overall analysis only), and all models adjusted for age, sex, site, nativity, smoking status, total alcoholic drinks per week, education, household income, marital status, depressive and anxiety symptoms, baseline visit season, physical activity, energy intake, and health insurance status.

[^7]: Abbreviations: OR (Odds ratio); 95% CI (95% confidence interval); DASH (Dietary Approaches to Stop Hypertension); MetS (metabolic syndrome); HDL (high density lipoprotein).

[^8]: Significant at p \< 0.05.

[^9]: Significant at p \< 0.001.

[^10]: Denotes the p-value for a product term between DASH score and Hispanic/Latino heritage group for each outcome.

[^11]: The overall model adjusted for Hispanic/Latino heritage group (overall analysis only), and all models adjusted for age, sex, site, nativity, smoking status, total alcoholic drinks per week, education, household income, marital status, depressive and anxiety symptoms, baseline visit season, physical activity, energy intake, health insurance status, and medication use in the appropriate analyses (lipid-lowering medication for the triglycerides and HDL analyses only, antihypertensive medication for systolic BP and diastolic BP only, antidiabetic medication for fast glucose).

[^12]: Abbreviations: 95% CI (95% confidence interval); DASH (Dietary Approaches to Stop Hypertension); MetS (metabolic syndrome); HDL (high density lipoprotein).

[^13]: B = Effect estimate from linear regression models.

[^14]: p \< 0.05.

[^15]: p \< 0.01.

[^16]: p \< 0.001.

[^17]: Denotes the p-value for a product term between DASH score and Hispanic/Latino heritage group for each outcome.
